
[ Mon, Mar 11th 2019 ]: WOPRAI

[ Fri, Mar 08th 2019 ]: WOPRAI
[ Fri, Mar 08th 2019 ]: WOPRAI
[ Fri, Mar 08th 2019 ]: WOPRAI
[ Fri, Mar 08th 2019 ]: WOPRAI
[ Fri, Mar 08th 2019 ]: WOPRAI
[ Fri, Mar 08th 2019 ]: WOPRAI
[ Fri, Mar 08th 2019 ]: WOPRAI
[ Fri, Mar 08th 2019 ]: WOPRAI
[ Fri, Mar 08th 2019 ]: WOPRAI
[ Fri, Mar 08th 2019 ]: WOPRAI

[ Thu, Mar 07th 2019 ]: WOPRAI
[ Thu, Mar 07th 2019 ]: WOPRAI
[ Thu, Mar 07th 2019 ]: WOPRAI
[ Thu, Mar 07th 2019 ]: WOPRAI
[ Thu, Mar 07th 2019 ]: WOPRAI
[ Thu, Mar 07th 2019 ]: WOPRAI
[ Thu, Mar 07th 2019 ]: WOPRAI
[ Thu, Mar 07th 2019 ]: WOPRAI
[ Thu, Mar 07th 2019 ]: WOPRAI
[ Thu, Mar 07th 2019 ]: WOPRAI

[ Wed, Mar 06th 2019 ]: WOPRAI
[ Wed, Mar 06th 2019 ]: WOPRAI
[ Wed, Mar 06th 2019 ]: WOPRAI
[ Wed, Mar 06th 2019 ]: WOPRAI
[ Wed, Mar 06th 2019 ]: WOPRAI
[ Wed, Mar 06th 2019 ]: WOPRAI
[ Wed, Mar 06th 2019 ]: WOPRAI
[ Wed, Mar 06th 2019 ]: WOPRAI
[ Wed, Mar 06th 2019 ]: WOPRAI

[ Tue, Mar 05th 2019 ]: WOPRAI
[ Tue, Mar 05th 2019 ]: WOPRAI
[ Tue, Mar 05th 2019 ]: WOPRAI
[ Tue, Mar 05th 2019 ]: WOPRAI
[ Tue, Mar 05th 2019 ]: WOPRAI
[ Tue, Mar 05th 2019 ]: WOPRAI
[ Tue, Mar 05th 2019 ]: WOPRAI
[ Tue, Mar 05th 2019 ]: WOPRAI
[ Tue, Mar 05th 2019 ]: WOPRAI

[ Mon, Mar 04th 2019 ]: WOPRAI
[ Mon, Mar 04th 2019 ]: WOPRAI
[ Mon, Mar 04th 2019 ]: WOPRAI
[ Mon, Mar 04th 2019 ]: WOPRAI
[ Mon, Mar 04th 2019 ]: WOPRAI
[ Mon, Mar 04th 2019 ]: WOPRAI
[ Mon, Mar 04th 2019 ]: WOPRAI
[ Mon, Mar 04th 2019 ]: WOPRAI
[ Mon, Mar 04th 2019 ]: WOPRAI
David Risinger Downgraded (TEVA) to Hold and Held Target at $17 on, Mar 6th, 2019


🞛 This publication is a summary or evaluation of another publication
David Risinger of Morgan Stanley, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Held Target at $17 on, Mar 6th, 2019.
David has made no other calls on TEVA in the last 4 months.
There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vamil Divan of "Credit Suisse" Maintained at Hold with Decreased Target to $20 on, Thursday, February 14th, 2019
- David Amsellem of "Piper Sandler" Upgraded from Sell to Hold and Increased Target to $16 on, Wednesday, January 23rd, 2019
These are the ratings of the 2 analyists that currently disagree with David
- Elliot Wilbur of "Raymond James" Upgraded from Hold to Buy on, Thursday, February 14th, 2019
- Jason Gerberry of "B of A Securities" Upgraded from Sell to Strong Buy on, Thursday, January 3rd, 2019
Similar Stocks and Investing Publications
[ Thu, Feb 14th 2019 ]: WOPRAI
[ Thu, Feb 14th 2019 ]: WOPRAI
[ Fri, Nov 02nd 2018 ]: WOPRAI
[ Thu, May 31st 2018 ]: WOPRAI
[ Mon, May 07th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Mon, Feb 12th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Fri, Feb 09th 2018 ]: WOPRAI
[ Mon, Nov 06th 2017 ]: WOPRAI
[ Fri, Nov 03rd 2017 ]: WOPRAI
[ Fri, Oct 20th 2017 ]: WOPRAI